Teclistamab (JNJ-64007957) is a human bispecific monoclonal antibody targeting the CD3 receptor expressed on the surface of t-cells and the b-cell maturation antigen (BCMA) expressed on the surface of malignant multiple myeloma b-lineage cells for the treatment of relapsed and refractory multiple myeloma.
Purity:
0.95
CAS Number:
[2119595-80-9]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted